DBV TECHNOLOGIES (EPA:DBV) | Finanzwire

Basculer en Français

10562	Companies
223495	Keywords
152500	Articles
118268	Press releases

Home
Companies
DBV TECHNOLOGIES

BRIEF

published on 06/09/2026 at 13:05, 5 days 10 hours ago

DBV Technologies cancels a presentation at a Goldman Sachs conference

Goldman Sachs DBV Technologies Daniel Tassé Health Conference VIASKIN® Patch
BRIEF

published on 06/09/2026 at 13:05, 5 days 10 hours ago

DBV Technologies Adjusts Attendance at Global Conference

DBV Technologies Food Allergies Epicutaneous Immunotherapy VIASKIN Patch Goldman Sachs Conference
PRESS RELEASE

published on 06/09/2026 at 13:00, 5 days 10 hours ago

DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference
DBV Technologies to participate in 1-on-1 investor meetings at Goldman Sachs Annual Global Healthcare Conference. CEO unavailable for fireside chat. Company focused on developing food allergy treatments with VIASKIN patch technology

Investor Meetings DBV Technologies Food Allergies Goldman Sachs Conference VIASKIN Patch Technology
BRIEF

published on 06/08/2026 at 22:40, 6 days ago

DBV Technologies: New advances in the treatment of peanut allergy

Immunotherapy DBV Technologies Viaskin Peanut Peanut Allergy SPEED Study
BRIEF

published on 06/08/2026 at 22:40, 6 days ago

DBV Technologies Unveils Promising Data on Peanut Allergy Treatments

DBV Technologies Viaskin Peanut Patch Peanut Allergy Treatment VITESSE Study THRIVE Study
PRESS RELEASE

published on 06/08/2026 at 22:35, 6 days ago

DBV Technologies to Present New Positive Data from VITESSE Study and Preview Recently Initiated THRIVE Study at the EAACI Congress 2026
DBV Technologies to present new positive data from VITESSE study and preview THRIVE study at EAACI Congress 2026. VIASKIN Peanut Patch efficacy in peanut-allergic children with atopic comorbidities

DBV Technologies Viaskin Peanut Patch VITESSE Study THRIVE Study EAACI Congress 2026
BRIEF

published on 06/08/2026 at 09:37, 6 days 13 hours ago

DBV Technologies: JP Morgan Chase & Co. falls below the 10% threshold

Share Capital Voting Rights Threshold Crossing DBV Technologies JP Morgan Chase
BRIEF

published on 06/05/2026 at 22:35, 9 days ago

DBV Technologies presents at the Goldman Sachs Global Healthcare Conference

Immunotherapy DBV Technologies Viaskin Food Allergies Goldman Sachs Conference
BRIEF

published on 06/05/2026 at 22:35, 9 days ago

DBV Technologies to Present at Goldman Sachs Healthcare Conference

DBV Technologies Food Allergies Epicutaneous Immunotherapy VIASKIN Patch Goldman Sachs Healthcare Conference
PRESS RELEASE

published on 06/05/2026 at 22:30, 9 days ago

DBV Technologies to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
DBV Technologies to participate in Goldman Sachs 47th Annual Global Healthcare Conference. Developing treatment options for food allergies with VIASKIN patch technology

Clinical Trials DBV Technologies Food Allergies Goldman Sachs Conference VIASKIN Patch Technology

Accesswire

Published on 06/13/2026 at 04:50, 1 day 18 hours ago

BTU Additional Details Regarding Recent Acquisition
Published on 06/13/2026 at 02:00, 1 day 21 hours ago

Battery X Metals Appoints Automotive Industry Professional from Canadian Subsidiary of One of the World's Leading Premium Automobile Manufacturers, Headquartered in Munich, Germany, to its Advisory Board to Advance Commercialization of Its Patent-Pending
Published on 06/12/2026 at 23:15, 2 days ago

BioNxt Announces Non-Brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
Published on 06/12/2026 at 22:30, 2 days ago

Fox River Provides Reminder To Vote And Updated Dissent Rights
Published on 06/12/2026 at 15:14, 2 days 8 hours ago

Reeflex Solutions Inc. Reports Voting Results From Annual and Special Meeting of Shareholders

View all ACCESSWIRE

EQS Group

Published on 06/14/2026 at 14:50, 8 hours 30 minutes ago

Zug voters say yes to Metalli development plan
Published on 06/14/2026 at 13:30, 9 hours 50 minutes ago

Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress
Published on 06/14/2026 at 10:42, 12 hours 38 minutes ago

LightOn Demonstrates the Flexibility of Its OCR Model by Adapting It to Arabic Through Targeted Training.
Published on 06/13/2026 at 08:18, 1 day 15 hours ago

EQS-Adhoc: AT&S Austria Technologie & Systemtechnik AG: AT&S expands AI substrate capacity in Kulim and increases outlook for 2026/27
Published on 06/13/2026 at 01:05, 1 day 22 hours ago

OpenText to Create 400 Jobs with €105 Million Investment in Cork and Galway to Expand Agentic AI and Sovereign Cloud in Europe

Les Echos

Published on 06/12/2026 at 18:31, 2 days 4 hours ago

Share retention commitments (Dutreil agreement)
Published on 06/12/2026 at 10:34, 2 days 12 hours ago

CHANGE IN THE SHARE CAPITAL
Published on 06/12/2026 at 09:00, 2 days 14 hours ago

Pricing of Green Senior Secured Notes due 2031 by Neoen FINCO PLC
Published on 06/11/2026 at 20:30, 3 days 2 hours ago

Mersen joins the SBF 120 index
Published on 06/11/2026 at 17:45, 3 days 5 hours ago

BAIKOWSKI: Annual General Meeting of June 11, 2026 - Dividend of €0.30 per share, to be paid out on June 30, 2026

View all LES ECHOS COMFI WIRE